BE3A Score

Online calculator

Ref: El-Sherif O, Jiang ZG, Curry MP et al. Baseline Factors Associated with Improvements in Decompensated Cirrhosis in Patients with HCV. Gastroenterology 2018 [In press]

The BE3A Score is a tool designed to assist clinicians to predict the clinical outcome of direct anti-viral treatment among patients with decompensated HCV cirrhosis (Child-Pugh B or C) in 36 weeks since the beginning of treatment.

BMI (kg/m2)
Encephalopathy (Check if present)
Ascites (Check if present)
Albumin (g/dL)
BMI: body mass index